24 August 2020

Recall,Lifting Suspension and Safety updates of a Pharmaceutical Product

Reference: CIR-2020-00000262

To all health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

- Recall five lots of pharmaceutical product Ventolin Nebules- 2.5mg/2.5ml

- Safety Alerts for Medical Device Non- contact forehead – infrared thermometer IM-9001

- Prescribing Naloxone with All patients when prescribing Opioid pain relievers or medicines to treat opioid use disorder, Opioid & Naloxone

- Notification of discrepancy in the Arabic section of product information leaflet Revlimid (lenalidomide) 5mg, 10mg, 15mg, and 25mg capsules

- Medical device recall BodyGuard Infusion Administration Sets

-Lifting the suspension of registration, importation and marketing of Product Cipropharm 250mg & 500mg Tablets

-Lifting the recall of the pharmaceutical product Amydramine Expectorant Syrup

- Lifting the recall for five lots of pharmaceutical product Ventolin Nebules- 2.5mg/2.5ml

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Ventolin Nebules- 2.5mg 2.5ml.pdf:

View Document

Non- contact forehead – infrared thermometer IM-9001.pdf:

View Document

Opioid _ Naloxone.pdf:

View Document

Revlimid (lenalidomide) 5mg, 10mg, 15mg, and 25mg capsules.pdf:

View Document

BodyGuard Infusion Administration Sets Medical Device Recall.pdf:

View Document

Lifting the suspension of registration, importation and marketing of Product Cipropharm 250mg _ 500mg Tablets.pdf:

View Document

lifting the recall of Amydramine Expectorant Syrup.pdf:

View Document

Lifting the recall for five lots of pharmaceutical product Ventolin Nebules- 2.5mg per 2.5ml.pdf:

View Document